Secondary myelodysplastic syndromes identified via next-generation sequencing in a non-small cell lung cancer patient

BACKGROUND: Myelodysplastic syndrome (MDS) is a group of clonal disorders characterized by ineffective and dysplastic hematopoiesis in the bone marrow with a high risk of progression to leukemia. Many studies have demonstrated that chemo-radiotherapy for cancer patients and exposure to certain chemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yongzhi, Chen, Xialin, Jiang, Keran, Zhang, Ding, Tao, Feng, Ni, Dan, Zhang, Jun, Wu, Lixin, Cai, Jinping, Jiang, Libin, Yu, GenHua, Shi, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691080/
https://www.ncbi.nlm.nih.gov/pubmed/34930266
http://dx.doi.org/10.1186/s12920-021-01147-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691080/
https://www.ncbi.nlm.nih.gov/pubmed/34930266
http://dx.doi.org/10.1186/s12920-021-01147-y

Ejemplares similares